KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Total Non-Current Liabilities (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $1.7 billion as the latest value for Q2 2025.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $1.7 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $1.7 billion, a N/A change, with the full-year FY2024 number at $1.6 billion, up 2.06% from a year prior.
  • Total Non-Current Liabilities was $1.7 billion for Q2 2025 at Halozyme Therapeutics, up from $1.6 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 billion in Q2 2025 to a low of -$423.2 million in Q2 2022.
  • A 5-year average of $1.2 billion and a median of $1.6 billion in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 113.19% in 2021, then decreased 1.66% in 2023.
  • Halozyme Therapeutics' Total Non-Current Liabilities stood at $906.9 million in 2021, then surged by 80.72% to $1.6 billion in 2022, then dropped by 1.66% to $1.6 billion in 2023, then rose by 2.06% to $1.6 billion in 2024, then grew by 3.12% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HALO's Total Non-Current Liabilities are $1.7 billion (Q2 2025), $1.6 billion (Q4 2024), and $1.6 billion (Q4 2023).